BX Swiss TOP 30 CHF
1.252,73
PKT
+4,72
PKT
+0,38
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.03.17 | Nestlé buy | Deutsche Bank AG | |
23.03.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
23.03.17 | Novartis buy | Kepler Cheuvreux | |
23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
23.03.17 | Roche buy | Société Générale Group S.A. (SG) | |
23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
23.03.17 | Roche buy | Deutsche Bank AG | |
23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.03.17 | Holcim Neutral | UBS AG | |
21.03.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
21.03.17 | Swiss Re Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
17.03.17 | Novartis Hold | Deutsche Bank AG | |
17.03.17 | Nestlé buy | Goldman Sachs Group Inc. | |
17.03.17 | Givaudan Neutral | Goldman Sachs Group Inc. | |
17.03.17 | Nestlé Underperform | Macquarie Research | |
17.03.17 | Givaudan verkaufen | Bernstein Research | |
16.03.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
16.03.17 | ABB (Asea Brown Boveri) Outperform | Robert W. Baird & Co. Incorporated | |
15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
14.03.17 | UBS overweight | JP Morgan Chase & Co. | |
14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.03.17 | UBS Neutral | JP Morgan Chase & Co. | |
14.03.17 | Holcim buy | Deutsche Bank AG | |
14.03.17 | Novartis Neutral | UBS AG | |
13.03.17 | Nestlé overweight | JP Morgan Chase & Co. | |
10.03.17 | Novartis Hold | Deutsche Bank AG | |
10.03.17 | Zurich Insurance neutral | Robert W. Baird & Co. Incorporated | |
09.03.17 | Novartis buy | Jefferies & Company Inc. | |
09.03.17 | Roche buy | Jefferies & Company Inc. | |
08.03.17 | Novartis Underweight | Barclays Capital | |
08.03.17 | Roche overweight | Barclays Capital | |
08.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
08.03.17 | UBS buy | Goldman Sachs Group Inc. | |
08.03.17 | UBS Neutral | Goldman Sachs Group Inc. | |
07.03.17 | UBS buy | Citigroup Corp. | |
07.03.17 | Novartis Underperform | BNP PARIBAS | |
06.03.17 | UBS Hold | Deutsche Bank AG | |
06.03.17 | UBS Hold | Deutsche Bank AG | |
06.03.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG |